Friday, June 07, 2024 8:48:59 AM
Thks SkyLimit for leading to “Catacombs”
Sio Capital Mgmt will do MORE:
Historically I do get the LAST LAUGH whether the aftermath of
Restarting Supply Chain post COVID leading to INFLATION
Central Bankers kept Interest Rates from 2015-2022 Too LOW TOO LONG
MORON was The CULPRIT disowning ALL except his own failures to govern.
Servicing the National Debt caused by MoRON’s 2017 Tax ACT is now larger than annual DEFENSE Budget!
ALL has been DOCUMENTED!
DIFFERENT STROKES for DIFFERENT FOLKS
Sio Capital Mgmt will do MORE:
BTW
— maverick_1 (@maveric92283613) June 6, 2024
IMHO The Inscrutable MAESTRO
with her leverage strategically & her decades of transactions
designed it that way!
Unfortunately the PAST as related by SingleStock who was BasinStBlues is MISLEADING!
— maverick_1 (@maveric92283613) June 7, 2024
A week after Woodford PR late Nov 2014 then +226% was SELF manufactured by Woodford buying on open Mkt driving NWzBO to $12!
No other institution than Woodfords Complex did that!
Interest rates zoomed in last two yrs:the focus of biotech $Mgrs IS on Cash burn, cash balances.
— maverick_1 (@maveric92283613) June 6, 2024
So lots of pre rev Bios had to either or both cut programs, layoffs.
Not surprised that DARK Forces had a field day.
w/Sio shd b different.
OR UK b excruciatingly LONG LABOR
Historically I do get the LAST LAUGH whether the aftermath of
Restarting Supply Chain post COVID leading to INFLATION
Central Bankers kept Interest Rates from 2015-2022 Too LOW TOO LONG
MORON was The CULPRIT disowning ALL except his own failures to govern.
Servicing the National Debt caused by MoRON’s 2017 Tax ACT is now larger than annual DEFENSE Budget!
ALL has been DOCUMENTED!
DIFFERENT STROKES for DIFFERENT FOLKS
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
